Stay updated on Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page.

Latest updates to the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page
- ChecktodayChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference24%
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe page has updated its status from 'Recruiting' to 'Active, not recruiting' and has changed the revision number from v2.16.11 to v2.16.12. Additionally, the date has been updated from 2025-02-06 to 2025-08-13.SummaryDifference2%
- Check22 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.3%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
- Check36 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.8%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.3%
Stay in the know with updates to Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page.